Definitive Contract N0018915C0021

Award Date 4/17/15
Potential Completion Date 9/30/20
Potential Value $912K
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Naval Supply Systems Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Camp Lejeune, NC 28547, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,426.36, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various medical supplies and equipment, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The contract does not have a set-aside designation, reflecting Fenwal's...
This federal contract award to Fenwal, Inc., a subsidiary of Fresenius Kabi, involves the delivery of a range of products and services to support transfusion medicine and cell therapy applications for various U.S. government agencies. The $178,662.00 Firm Fixed Price contract, awarded on July 12, 2018, includes the supply of blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. Fenwal has provided these...
This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Fenwal, Inc., a subsidiary of Fresenius Kabi, to provide blood bags for the military. The contract has a potential value of $100,519.90 and a completion date of August 31, 2022. Fenwal is a global blood technology company that has received numerous federal contract awards as a prime contractor to provide blood collection, separation, storage, and transfusion...
This federal contract award to Fenwal, Inc., a subsidiary of Fresenius Kabi, was made by the U.S. Army Medical Command (MEDCOM) for the purchase of CPD/ADSOL DBL WB RZ-2000 blood bags and related equipment. The $143,319.60 firm-fixed-price contract has an ultimate completion date of September 30, 2016 and does not have a set-aside designation. Fenwal, a global blood technology company, has established itself as a key supplier to various federal agencies, primarily supporting transfusion medicine...
This federal contract award is for the purchase of blood collection supplies and equipment from Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract, valued at $5,743.25, was awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc. on March 21, 2025, with a performance period ending on March 26, 2025. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Fenwal, Inc. is a foreign-owned, for-profit...
This federal contract award, valued at $8,054.68, was issued by the Defense Health Agency (DHA) to Fenwal, Inc., a subsidiary of Fresenius Kabi. Fenwal is a global provider of blood collection, separation, storage, and transfusion products and services, and has served as a supplier to various federal agencies, including the Department of Defense, Department of Veterans Affairs, and National Institutes of Health. The contract is for the delivery of 4R4424 CENTRIFUGE BAGS, a specialized product...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
This federal contract award from the Defense Logistics Agency (DLA) is for the provision of blood collection supplies to support medical and healthcare initiatives. The $5,743.25 firm-fixed-price purchase order was awarded to Fenwal, Inc., a foreign-owned, for-profit manufacturer of blood collection, separation, storage, and transfusion products and services. The contract has a performance period ending on March 26, 2025 and does not include a set-aside designation. Fenwal, Inc. is a key...
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of blood collection and transfusion products. The $3,303.84 contract is for the delivery of blood packs with anticoagulant, which support healthcare and biomedical research initiatives. Fenwal has established itself as a key supplier to various federal agencies, including the Department of Veterans Affairs, National Institutes of Health, and Defense...
This federal contract award, number SPE2DP24P0460, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi that specializes in blood collection, separation, storage, and transfusion products and services. The $10,300.80 firm-fixed-price purchase order is for the delivery of washing solution, which is likely to support transfusion medicine and cell therapy applications for the Department of Defense and other federal agencies....

This is a definitive contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company, for the procurement of blood collection bags. The contract has a firm fixed price, a ceiling value of $911,730.34, and an ultimate completion date of September 30, 2020. Fenwal, Inc. has been a registered vendor with the U.S. federal government since 2007 and has established itself as a key supplier to various federal agencies, primarily supporting transfusion medicine and cell therapy applications. The contract does not have a set-aside designation, reflecting Fenwal's unique capabilities in this field. Fenwal has also served as a subcontractor to prime contractors such as Leidos Biomedical Research Inc., providing cell processing systems for federal projects.

Generated 4/1/25, 8:02 PM